Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Ming Zhou

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
ACS Chemical Biology|November 25, 2015
The Bromodomain: A New Target in Emerging Epigenetic MedicineSteven G Smith, Ming-Ming Zhou
Drug Discovery Today|November 8, 2021
Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signalingBharath Kumar Gajjela, Ming-Ming Zhou
Results and Problems in Cell Differentiation|August 17, 2006
Structure and function of protein modules in chromatin biologyKyoko L Yap, Ming-Ming Zhou
Current Opinion in Chemical Biology|May 19, 2023
Bromodomain inhibitors and therapeutic applicationsBharath Kumar Gajjela, Ming-Ming Zhou
Critical Reviews in Biochemistry and Molecular Biology|October 7, 2010
Keeping it in the family: diverse histone recognition by conserved structural foldsKyoko L Yap, Ming-Ming Zhou
Biochemistry|February 4, 2011
Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcriptionKyoko L Yap, Ming-Ming Zhou
Nature Reviews. Drug Discovery|November 21, 2024
Targeting lysine acetylation readers and writersMing-Ming Zhou, Philip A Cole
Journal of Medicinal Chemistry|October 1, 2011
Structure-guided design of a methyl donor cofactor that controls a viral histone H3 lysine 27 methyltransferase activityJiaojie Li, Hua Wei, Ming-Ming Zhou
Structure (London, England : 1993)|May 19, 2009
Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulatorSuvobrata Chakravarty, Lei Zeng, Ming-Ming Zhou
Biochimica Et Biophysica Acta|April 2, 2014
The bromodomain: from epigenome reader to druggable targetRoberto Sanchez, Jamel Meslamani, Ming-Ming Zhou
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
ACS Chemical Biology|November 25, 2015
The Bromodomain: A New Target in Emerging Epigenetic MedicineSteven G Smith, Ming-Ming Zhou
Drug Discovery Today|November 8, 2021
Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signalingBharath Kumar Gajjela, Ming-Ming Zhou
Results and Problems in Cell Differentiation|August 17, 2006
Structure and function of protein modules in chromatin biologyKyoko L Yap, Ming-Ming Zhou
Current Opinion in Chemical Biology|May 19, 2023
Bromodomain inhibitors and therapeutic applicationsBharath Kumar Gajjela, Ming-Ming Zhou
Critical Reviews in Biochemistry and Molecular Biology|October 7, 2010
Keeping it in the family: diverse histone recognition by conserved structural foldsKyoko L Yap, Ming-Ming Zhou
Biochemistry|February 4, 2011
Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcriptionKyoko L Yap, Ming-Ming Zhou
Nature Reviews. Drug Discovery|November 21, 2024
Targeting lysine acetylation readers and writersMing-Ming Zhou, Philip A Cole
Journal of Medicinal Chemistry|October 1, 2011
Structure-guided design of a methyl donor cofactor that controls a viral histone H3 lysine 27 methyltransferase activityJiaojie Li, Hua Wei, Ming-Ming Zhou
Structure (London, England : 1993)|May 19, 2009
Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulatorSuvobrata Chakravarty, Lei Zeng, Ming-Ming Zhou
Biochimica Et Biophysica Acta|April 2, 2014
The bromodomain: from epigenome reader to druggable targetRoberto Sanchez, Jamel Meslamani, Ming-Ming Zhou
Pageof 17